Dabigatran

Generic Name
Dabigatran
Brand Names
Dabigatran Etexilate Leon Farma, Dabigatran Etexilate Accord, Pradaxa
Drug Type
Small Molecule
Chemical Formula
C25H25N7O3
CAS Number
211914-51-1
Unique Ingredient Identifier
I0VM4M70GC
Background

Dabigatran is the active form of the orally bioavailable prodrug dabigatran etexilate.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Medical Need of OAC Reversal

First Posted Date
2017-08-18
Last Posted Date
2019-03-04
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
53969
Registration Number
NCT03254147
Locations
🇯🇵

Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

First Posted Date
2017-06-16
Last Posted Date
2019-01-30
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
36000
Registration Number
NCT03189069

Start or STop Anticoagulants Randomised Trial (SoSTART)

First Posted Date
2017-05-15
Last Posted Date
2022-04-08
Lead Sponsor
University of Edinburgh
Target Recruit Count
203
Registration Number
NCT03153150
Locations
🇬🇧

Frimley Park Hospital, Frimley, United Kingdom

🇬🇧

Gloucestershire Royal Hospital, Gloucester, United Kingdom

🇬🇧

Pinderfields Hospital, Wakefield, United Kingdom

and more 64 locations

Use of Direct Oral Anticoagulants in UK

First Posted Date
2017-04-18
Last Posted Date
2020-04-17
Lead Sponsor
Bayer
Target Recruit Count
31336
Registration Number
NCT03119116
Locations
🇬🇧

Many Locations, Multiple Locations, United Kingdom

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

First Posted Date
2016-12-06
Last Posted Date
2021-01-13
Lead Sponsor
Asan Medical Center
Target Recruit Count
120
Registration Number
NCT02982850
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

First Posted Date
2016-10-18
Last Posted Date
2020-11-10
Lead Sponsor
University of Pavia
Target Recruit Count
300
Registration Number
NCT02935855
Locations
🇮🇹

IRCCS Policlinico San Matteo, Pavia, Italy

Use of Public Health Surveillance Models in the French National Health System Database

First Posted Date
2016-09-19
Last Posted Date
2018-09-05
Lead Sponsor
Centre Hospitalier Universitaire de la Réunion
Target Recruit Count
814446
Registration Number
NCT02904499
Locations
🇫🇷

University Hospital of Reunion Island, Saint Denis, Reunion Island, France

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

First Posted Date
2016-09-01
Last Posted Date
2016-09-01
Lead Sponsor
University College, London
Target Recruit Count
12
Registration Number
NCT02885961

Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

Phase 2
Terminated
Conditions
Thrombosis
Bleeding
Interventions
Drug: Phenprocoumon
Drug: Dabigatran
First Posted Date
2016-08-19
Last Posted Date
2016-08-19
Lead Sponsor
Daniel Zimpfer, MD
Target Recruit Count
16
Registration Number
NCT02872649
Locations
🇦🇹

Medical Univerity Vienna, Vienna, Austria

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

First Posted Date
2016-06-07
Last Posted Date
2016-06-07
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
28000
Registration Number
NCT02792335
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy